Intimation of authorization under regulation 30(5) (LODR).
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Novelix Pharmaceuticals has disclosed to BSE the names of its three Key Managerial Personnel authorized to determine materiality of events and make stock exchange disclosures under SEBI Listing Regulations. The authorized persons are: Venkateshwarlu Pulluru (Whole-time Director), Bhoomika Choudhary (CFO), and Nishita Kalantri (Company Secretary & Compliance Officer). This filing is dated 31st May 2026. The company is headquartered in Hyderabad. This is a standard regulatory compliance disclosure identifying authorized signatories — not a material corporate event or price-sensitive information.
No direct impact on the stock price. This is a routine administrative filing that simply identifies the company's authorized signatories for SEBI regulatory disclosures. Shareholders do not need to take any action.